English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  51794951    線上人數 :  945
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"jeng l b"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 11-20 / 28 (共3頁)
<< < 1 2 3 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-05-31T02:57:26Z Osteoblast-derived TGF-β1 stimulates IL-8 release through AP-1 and NF-κB in human cancer cells Fong Y.-C.; Maa M.-C.; Tsai F.-J.; Chen W.-C.; Lin J.-G.; Jeng L.-B.; RONG-SEN YANG; Fu W.-M.; Tang C.-H.
臺大學術典藏 2021-03-18T05:59:32Z The accuracy of ultrasonography and 201Tl-99mTc subtraction scan in localization of parathyroid lesions. Liou M.J.; Huang H.S.; Lin J.D.; Huang B.Y.; Hsueh C.; Jeng L.B.; KAI-YUAN TZEN
臺大學術典藏 2021-02-02T02:21:32Z Hepatic resection for hepatocellular carcinoma patients on hemodialysis for Uremia: A nationwide cohort study Yeh C.-C.; Lin J.-T.; Jeng L.-B.; Charalampos I.; Chen T.-T.; Lee T.-Y.; MING-SHIANG WU; Kuo K.N.; Liu Y.-Y.; Wu C.-Y.
臺大學術典藏 2021-02-02T02:21:22Z Nonsteroidal anti-inflammatory drugs are associated with reduced risk of early hepatocellular carcinoma recurrence after curative liver resection: A nationwide cohort study Yeh C.-C.; Lin J.-T.; Jeng L.-B.; Ho H.J.; Yang H.-R.; MING-SHIANG WU; Kuo K.N.; Wu C.-Y.
臺大學術典藏 2020-11-19T03:19:55Z Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage Liu C.-J.; PO-HUANG LEE; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin P.-W.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Lee C.-C.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; Chen P.-J.
臺大學術典藏 2020-11-19T03:19:36Z Long-term results of a randomized, observation-controlled, phase III Trial of Adjuvant Interferon alfa-2b in hepatocellular carcinoma after curative resection Chen L.-T.;Chen M.-F.;Li L.-A.;Po-Huang Lee;Jeng L.-B.;Lin D.-Y.;Wu C.-C.;Mok K.-T.;Chen C.-L.;Lee W.-C.;Chau G.-Y.;Chen Y.-S.;Lui W.-Y.;Hsiao C.-F.;Whang-Peng J.;Chen P.-J.; Chen L.-T.; Chen M.-F.; Li L.-A.; PO-HUANG LEE; Jeng L.-B.; Lin D.-Y.; Wu C.-C.; Mok K.-T.; Chen C.-L.; Lee W.-C.; Chau G.-Y.; Chen Y.-S.; Lui W.-Y.; Hsiao C.-F.; Whang-Peng J.; Chen P.-J.
臺大學術典藏 2020-11-19T03:19:23Z Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence Lin Y.-J.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Yang M.-D.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; Chen P.-J.; Liu C.-J.; Chang J.; PO-HUANG LEE; Lin D.-Y.; Wu C.-C.; Jeng L.-B.
臺大學術典藏 2020-11-19T03:19:19Z Pre-existing diabetes and risks of morbidity and mortality after liver transplantation: A nationwide database study in an Asian population PO-HUANG LEE; Jeng L.-B.; Kao C.-H.; Wang H.-H.; Wang Y.-C.; Tsai M.-S.
臺大學術典藏 2020-11-02T02:04:43Z Hepatic resection for hepatocellular carcinoma patients on hemodialysis for Uremia: A nationwide cohort study Wu C.-Y.; Liu Y.-Y.; Kuo K.N.; Yeh C.-C.; Lin J.-T.; Jeng L.-B.; Charalampos I.; Chen T.-T.; Lee T.-Y.; MING-SHIANG WU
臺大學術典藏 2020-02-26T01:33:18Z Large-scale bicortical skull bone regeneration using ex vivo replication-defective adenoviral-mediated bone morphogenetic protein-2 gene-transferred bone marrow stromal cells and composite biomaterials Chang, S.C.-N.; Lin, T.-M.; Chung, H.-Y.; Chen, P.K.-T.; Lin, F.-H.; Lou, J.; Jeng, L.-B.; FENG-HUEI LIN

顯示項目 11-20 / 28 (共3頁)
<< < 1 2 3 > >>
每頁顯示[10|25|50]項目